Recent Updates
Recently added Catalysts

NaF

Phase 3

Caries | Small molecule | Other |GSK plc|Last Updated: Jan 1, 2015

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedPLACEBO_CONTROLLEDBiomarker
Total Trials1
Total Enrollment57
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT00708097In Situ Caries Efficacy of Fluoride ToothpastesPHASE3 COMPLETED 57Apr 1, 2008Jul 1, 2008Jan 1, 20151 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Percentage Surface Microhardness Recovery (%SMHR) of Sound Enamel Specimens Exposed to NaF Toothpaste (1450ppmF) and NaF Toothpaste (1400ppmF)
Baseline to 14 days

SMH test was used to assess mineral status of partially demineralized enamel specimens using Wilson 2100 Hardness tester. SMH was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening/demineralization while decrease in the indentation represents rehardening/ remineralization of enamel surface. Percent SMHR was calculated from indentation values of enamel specimens at baseline(B); after intra-oral exposure(R) on Day 14; and after in-vitro demineralization(D) on Day 14 using formula \[(D-R)/(D-B)\]\*100.

Secondary Endpoints
Percentage SMHR of Sound Enamel Specimens Exposed to NaF Toothpaste (1450ppmF), NaF Toothpaste (1400ppmF), NaMFP/NaF Toothpaste (1450ppmF), NaF Toothpaste (675ppmF) and Placebo Toothpaste (0ppmF)
Baseline to 14 days
Percentage SMHR of Demineralized Enamel Specimens Exposed to NaF Toothpaste (1450ppmF), NaF Toothpaste (1400ppmF), NaF Toothpaste (675ppmF), NaMFP/NaF Toothpaste(1450ppmF) and Placebo Toothpaste (0ppmF)
Baseline to 14 days
Enamel Fluoride Uptake (Sound Enamel Specimens)
Baseline to 14 days
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingSINGLE
ModelCROSSOVER
PurposeTREATMENT
Treatment Arms
ArmTypeDescription
NaF toothpaste(1450 ppmF)EXPERIMENTALStudy toothpaste containing 1450 ppm F as NaF and 0.4% carbopol as excipient.
NaF toothpaste (1400 ppmF)ACTIVE_COMPARATORStudy toothpaste containing 1400 ppm F as NaF
NaMFP/NaF toothpaste (1450 ppmF)ACTIVE_COMPARATORReference toothpaste containing 1000 ppm F as NaMFP and 450 ppm F as NaF
NaF toothpaste (675 ppmF)ACTIVE_COMPARATORStudy toothpaste containing 675 ppm F as NaF
Placebo toothpaste (0 ppmF)PLACEBO_COMPARATORFluoride free placebo toothpaste (0 ppm F)
Interventions
NameTypeDescription
NaFDRUGFluoride
PlaceboDRUGPlacebo
NaMFPDRUGFluoride
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — 78 Years
SexALL
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: * Consent:Demonstrates understanding of the study and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form. * Age:Aged between 18 and 80 years. * Compliance:Understands and is willing,...

Countries:United States
Unlock Eligibility Criteria